1
Post-Authorisation Safety Study of Lesinurad
Condition(s):Gout; HyperuricemiaLast Updated:August 28, 2019Not yet recruiting
Lesinurad as an Intervention: 22 Clinical Trials, Page 1 of 3
Hide Studies Not Open or Pending
2
A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment
Condition(s):Gout; Chronic Kidney Disease (CKD)Last Updated:March 4, 2019Terminated
3
Lesinurad and Allopurinol Combination Extension Study in Gout
Condition(s):GoutLast Updated:January 24, 2017Completed
4
Bioavailability of Lesinurad and Intravenous [14C]Lesinurad
Condition(s):HealthyLast Updated:May 20, 2014Completed
5
Open-Label Lesinurad Monotherapy Extension Study in Gout
Condition(s):GoutLast Updated:May 26, 2016Completed
6
Lesinurad and Febuxostat Combination Extension Study in Gout
Condition(s):GoutLast Updated:January 30, 2018Completed
7
Lesinurad Tablet Bioequivalence
Condition(s):HealthyLast Updated:September 22, 2014Completed
8
Lesinurad Tablet Relative Bioavailability
Condition(s):HealthyLast Updated:September 22, 2014Completed
9
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
Condition(s):GoutLast Updated:February 12, 2016Completed
10
Lesinurad/Allopurinol 200/300 Fixed-Dose Combination (FDC) Tablets Bioequivalence.
Condition(s):GoutLast Updated:November 7, 2018Completed